BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

por LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE
Publicado 2016

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer

por Fu, Xin, Chen, Guo, Cai, Zhi-duan, Wang, Cong, Liu, Ze-zhen, Lin, Zhuo-yuan, Wu, Yong-ding, Liang, Yu-xiang, Han, Zhao-dong, Liu, Jun-chen, Zhong, Wei-De
Publicado 2016

Functional classification of prostate cancer-associated miRNAs through CRISPR/Cas9-mediated gene knockout

por Jiang, Fu-Neng, Liang, Yu-Xiang, Wei, Wang, Zou, Cui-Yun, Chen, Guan-Xing, Wan, Yue-Ping, Liu, Ze-Zhen, Yang, Yang, Han, Zhao-Dong, Zhu, Jian-Guo, Zhong, Wei-De
Publicado 2020

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer

por Zeng, Yan-Ru, Han, Zhao-Dong, Wang, Cong, Cai, Chao, Huang, Ya-Qiang, Luo, Hong-Wei, Liu, Ze-Zhen, Zhuo, Yang-Jia, Dai, Qi-Shan, Zhao, Hai-Bo, Liang, Yu-Xiang, Zhong, Wei-De
Publicado 2015

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment

por Jia, Zhenyu, Zhu, Jianguo, Zhuo, Yangjia, Li, Ruidong, Qu, Han, Wang, Shibo, Wang, Meiyue, Lu, Jianming, Chater, John M., Ma, Renyuan, Liu, Ze-zhen, Cai, Zhiduan, Wu, Yongding, Jiang, Funeng, He, Huichan, Zhong, Wei-De, Wu, Chin-Lee
Publicado 2019